Legal challenges facing Bayer for health concerns allegedly caused by the use of glyphosate more than doubled in the last quarter, the company recently disclosed to investors.

A trial in St. Louis involving a plaintiff who alleges exposure to Roundup caused her non-Hodgkin lymphoma has been delayed indefinitely, leading to speculation that Bayer and plaintiffs’ lawyers need the time to work out a settlement.

With an eye on the future of agriculture and the need to address shareholders and customers expectations, Bayer confirmed an ambitious plan to address climate change and a more sustainable farming future during events in Monheim, Germany, this week.

Pro- and anti-glyphosate companies and organizations lined up to praise — or bash — the active ingredient in the most widely applied herbicide in the world, in comments submitted to the Environmental Protection Agency last week.

Germany has decided it will ban glyphosate by the end of 2023, following in the footsteps of a decision by Austria this summer.

A California state court judge said she is “inclined” to significantly reduce a jury award given to an elderly couple who alleged that exposure to Roundup caused their non-Hodgkin lymphoma.

Despite some harsh words describing Monsanto’s conduct, a federal judge said last week he plans to reduce an $80 million award to a California man who claimed exposure to Roundup caused his non-Hodgkin lymphoma.

Glyphosate registrants defended their products as safe to use in comments submitted this week to the Agency for Toxic Substances and Disease Registry, which issued a report in April saying it could not “rule out” an association between exposure to glyphosate-based products and the risk of cancer.